FDA Is Backing First-of-Its-Kind mRNA-Based Flu Vaccine

A new kind of flu vaccine moved a step closer to the US market Thursday as federal health advisers recommended approval of the first one made with the same mRNA technology that was key to ending the COVID-19 pandemic. The Food and Drug Administration is evaluating Moderna's new shot, dubbed...